Papers List

Balls, M.   The need for recommitment to the three Rs and to serving together in the middle ground.    ATLA, 32, 1–3 (2004).   [Abstract]    [PDF]

Balls, M. and Combes, R.D.   The UK National Centre for the Three Rs: pathway to progress or mere fig leaf?    ATLA, 32, 61–64 (2004).   [Abstract]    [PDF]

Combes, R.D.   Peer review of validation studies: an assessment of the role of the OECD by reference to the validation of the uterotrophic assay for endocrine disruptors.    ATLA, 32, 111–117 (2004).   [Abstract]    [PDF]

Combes, R.D.   The case for taking account of metabolism when testing for potential endocrine disruptors in vitro.    ATLA, 32, 121–135 (2004).   [Abstract]    [PDF]

Combes, R.D.   The use of human cells in biomedical research and testing.    ATLA, 32(Suppl. 1), 43–49 (2004).   [Abstract]    [PDF]

Combes, R.D., Balls, M., Bansil, L., Barratt, M., Bell, D., Botham, P., Broadhead, C., Clothier, R., George, E., Fentem, J., Jackson, M., Indans, I., Loizou, G., Navaratnam, V., Pentreath, V., Phillips, B., Stemplewski, H. and Stewart, J.   The third FRAME Toxicity Committee: working toward greater implementation of alternatives in toxicity testing.    ATLA, 32(Suppl. 1), 635–642 (2004).   [Abstract]    [PDF]

Gray, A.C., Malton, J. and Clothier, R.H.   The development of a standardised protocol to measure squamous differentiation in stratified epithelia, by using the fluorescein cadaverine incorporation technique.    ATLA, 32, 91–100 (2004).   [Abstract]    [PDF]

Halder, M., Balls, M., Hendriksen, C. and Cussler, K.   ECVAM’s activities in promoting the three Rs in the quality control of biologicals.    ATLA, 32(Suppl. 1), 93–98 (2004).   [Abstract]    [PDF]

Worth, A.P. and Balls, M.   The principles of validation and the ECVAM validation process.    ATLA, 32(Suppl. 1), 623-629 (2004).   [Abstract]    [PDF]